CNTA
Geode Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
87,435
+26,994
| +45% | +$355K | ﹤0.01% | 3283 |
|
|
2025
Q1 | $869K | Buy |
60,441
+3,184
| +6% | +$45.8K | ﹤0.01% | 3352 |
|
|
2024
Q4 | $959K | Buy |
57,257
+660
| +1% | +$11.1K | ﹤0.01% | 3397 |
|
|
2024
Q3 | $905K | Buy |
56,597
+23,058
| +69% | +$369K | ﹤0.01% | 3388 |
|
|
2024
Q2 | $303K | Hold |
33,539
| – | – | ﹤0.01% | 3762 |
|
|
2024
Q1 | $379K | Hold |
33,539
| – | – | ﹤0.01% | 3706 |
|
|
2023
Q4 | $267K | Buy |
33,539
+1,706
| +5% | +$13.6K | ﹤0.01% | 3842 |
|
|
2023
Q3 | $206K | Buy |
31,833
+6,713
| +27% | +$43.4K | ﹤0.01% | 3971 |
|
|
2023
Q2 | $155K | Buy |
25,120
+2,434
| +11% | +$15.1K | ﹤0.01% | 4155 |
|
|
2023
Q1 | $87.3K | Buy |
22,686
+9,258
| +69% | +$35.6K | ﹤0.01% | 4389 |
|
|
2022
Q4 | $41K | Hold |
13,428
| – | – | ﹤0.01% | 4642 |
|
|
2022
Q3 | $53K | Buy |
+13,428
| New | +$53K | ﹤0.01% | 4755 |
|
|
2021
Q3 | – | Sell |
-9,513
| Closed | -$211K | – | 4863 |
|
|
2021
Q2 | $211K | Buy |
+9,513
| New | +$211K | ﹤0.01% | 4323 |
|